ARK Investment Management - BIONDVAX PHARMACEUTICALS LTD ownership

BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 21 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2021$37,000
-68.4%
9,778
-76.5%
0.00%
Q4 2020$117,000
-84.9%
41,566
+109.3%
0.00%
-100.0%
Q3 2020$776,00019,8560.01%
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
TRUE Private Wealth Advisors 12,000$46,0000.01%
Virtu Financial LLC 18,328$70,0000.01%
HRT FINANCIAL LP 31,961$121,0000.00%
ROYAL BANK OF CANADA 2,540$10,0000.00%
UBS Group AG 1$00.00%
NEXT Financial Group, Inc 1,350$5,0000.00%
CREDIT AGRICOLE S A 4,240$16,0000.00%
WELLS FARGO & COMPANY/MN 908$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,768$52,0000.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders